The Screen · Communication Services · Entertainment
Madison Square Garden Sports Corp.
MSGS · the NYSE · USD · Market cap $9.5B · 514 employees
Madison Square Garden Sports Corp.
FAIL · Does not pass the screen
393.65 USD
At the last full screen 2026-08-27
Screened 2026-08-27 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
Madison Square Garden Sports Corp. holds its Markdown at $393.65. Consolidating, no directional conviction, held for 49 days.
As held on the ledger · 2026-08-27
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 49 days
Price at the screen
$393.65
Valuation
1,230.16 trailing · -2,052.40 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.58
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
80.43%
Below 33%
Interest-bearing debt is 80.4% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
11.57%
Below 49%
Money owed to the company is 11.6% of assets, under the 49% limit.
Pass
Revenue purity
0.39%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. A 20.7% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus Buy. The average target sits +21% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Knicks and Rangers ownership comes with heavy losses
Owning two of New York's most famous sports teams sounds like easy money until the numbers land on the table. Madison Square Garden Sports shows revenue crawling at just 2 percent while profit margins sit at minus 2 percent and the forward multiple stretches to minus 643 times. Analysts may still say buy with a 432 dollar median target, yet our screen sees no opportunity here.
The business clears our ethical test and the teams carry obvious brand power, yet the combination of flat growth, ongoing losses and an unknown moat leaves nothing worth pursuing at the current price. A 9 percent margin of safety to our 432 dollar fair value does not move the needle when core operations remain unprofitable.
Sports franchises can swing sharply with performance, media deals and labour costs, so today's slim margins could widen or vanish without warning. We pass. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MSGS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 100%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (6 analysts) rates it buy, with a mean price target of $390.
2026-08-06Markup$405.05+5.3%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 100%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (6 analysts) rates it buy, with a mean price target of $390.
2026-07-18Markup$384.68+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 100%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (6 analysts) rates it buy, with a mean price target of $390.
2026-07-03Markup$384.68+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$384.68Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
